Meta Biomed Co., Ltd.

KOSDAQ:A059210 株式レポート

時価総額:₩94.1b

Meta Biomed 過去の業績

過去 基準チェック /56

Meta Biomedは、平均年間35.9%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間16.7% 12.5%収益成長率で 成長しています。 Meta Biomedの自己資本利益率は17.6%であり、純利益率は16.4%です。

主要情報

35.9%

収益成長率

36.2%

EPS成長率

Medical Equipment 業界の成長22.7%
収益成長率12.5%
株主資本利益率17.6%
ネット・マージン16.4%
前回の決算情報30 Jun 2024

最近の業績更新

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Recent updates

Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Feb 26
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Apr 11
Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Mar 14
Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Feb 03
Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Jan 13
Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Dec 26
Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Dec 08
Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 20
Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

収支内訳

Meta Biomed の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

KOSDAQ:A059210 収益、費用、利益 ( )KRW Millions
日付収益収益G+A経費研究開発費
30 Jun 2490,09114,73422,7905,314
31 Mar 2484,43812,30922,0164,368
31 Dec 2383,10110,29221,6384,538
30 Sep 2379,5456,78719,8524,353
30 Jun 2377,7473,14119,8434,374
31 Mar 2375,4284,64519,6914,711
31 Dec 2268,9421,87418,5104,343
30 Sep 2266,8837,12718,3374,491
30 Jun 2261,3728,60417,2824,219
31 Mar 2260,7958,83215,5923,624
31 Dec 2158,7809,38115,3713,339
30 Sep 2154,1834,49012,6323,048
30 Jun 2151,8614,19612,0172,724
31 Mar 2145,793-1,09312,5252,298
31 Dec 2044,998-3,09113,5182,227
30 Sep 2046,8232,03514,1802,070
30 Jun 2049,0751,98015,6372,032
31 Mar 2056,0345,44516,6172,405
31 Dec 1959,3915,52716,4032,453
30 Sep 1952,26815617,1992,395
30 Jun 1953,1926418,5902,433
31 Mar 1951,518-1,43517,5382,221
31 Dec 1852,58695317,9582,013
30 Sep 1864,158-4,13116,7422,425
30 Jun 1865,530-2,66615,1702,257
31 Mar 1866,563-2,75316,4732,167
31 Dec 1765,341-4,10415,9702,157
30 Sep 1766,53126218,5702,289
30 Jun 1764,329-63516,4862,348
31 Mar 1764,38376116,3382,333
31 Dec 1665,78463916,3932,382
30 Sep 1665,6392,24016,3171,422
30 Jun 1667,2361,47617,7891,486
31 Mar 1668,22732217,5241,497
31 Dec 1568,59280616,7681,394
30 Sep 1567,332-2,36916,9061,886
30 Jun 1566,230-3,08815,1721,721
31 Mar 1563,748-4,24214,4172,161
31 Dec 1461,365-4,95214,1022,071
30 Sep 1458,403-1,11712,6842,047
30 Jun 1459,885-61913,1392,303
31 Mar 1463,4231,75212,1581,777
31 Dec 1363,5181,96711,6521,777

質の高い収益: A059210は 高品質の収益 を持っています。

利益率の向上: A059210の現在の純利益率 (16.4%)は、昨年(4%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: A059210の収益は過去 5 年間で年間35.9%増加しました。

成長の加速: A059210の過去 1 年間の収益成長率 ( 369.1% ) は、5 年間の平均 ( 年間35.9%を上回っています。

収益対業界: A059210の過去 1 年間の収益成長率 ( 369.1% ) はMedical Equipment業界4%を上回りました。


株主資本利益率

高いROE: A059210の 自己資本利益率 ( 17.6% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘